As per Persistence Market Researchs latest revised industry analysis, the North America vet compounding pharmacies market is expected to witness high growth over the decade. The market is expected to increase from US$ 1.1 Bn in 2020 to over US$ 2.7 Bn by 2031, expanding at a CAGR of around 8.5%.
A compounded drug is a modification of its original form. The U.S. Food and Drug Administration (FDA) considers complex drugs as Extra Label Drugs. This means that a combination drug is a custom form of FDA-approved veterinary drug. The veterinarians composition must be done by either the veterinarian or the pharmacist who received the prescription from the veterinarian. Complex drugs are made on a case-by-case basis for specific patients or animals, and not in large quantities.
Demand for vet compounding pharmacies in North America is expected to be driven by increased pet adoption, rising awareness amongst pet owners, high cost of branded veterinary products, and growing preference of oral liquid formulations.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/33001
Availability of alternative dosage forms other than the commercially available veterinary drugs is an important factor for the growing market in North America. For example, anti-parasitic drugs for cattle and antiflea drugs for dogs and cats are the most successful transdermal drugs used from compounding pharmacies. Availability of dosage forms such as transdermal drug delivery, flavored gels, flavored treats or biscuits, and others will help the market experience high growth in the future.
Expanding their product portfolios and entering into strategic partnerships and mergers are some of the strategies adopted by key players in the North America vet compounding pharmacies market. Making the products and services offered by them more personalized and customized according to every pets needs is another key strategy that has been adopted by key players in the region.
For instance, on August 17 2018, Wedgewood Pharmacy merged with Diamondback Drugs animal-health pharmacies. The two pharmacies have the reputation of being the nations most trusted pharmacies, and this merger was made with the objective of expanding the product portfolio, speedy delivery of veterinary medications, and to improve and evolve their services to capture a larger market share.
Company Profiles:
Hoyes Pharmacy
Vertisis Custom Pharmacy
Smith Caldwell Drug Store
Sixth Avenue Medical Pharmacy
Doughertys Pharmacy
Triangle Compounding Pharmacy Inc.
Medisca Inc.
Wedgewood Pharmacy
Millers Pharmacy
Chiron Compounding Pharmacy
MEDS Canadian Compounding Pharmacy
Aurora Compounding
Pace Pharmacy
Victoria Compounding Pharmacy
Pratts Compounding Pharmacy
Peoples Choice Pharmacy
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/33001
Key Takeaways from Market Study
CNS agents and anti-infective agents are expected to provide a lucrative market opportunity to market players.
While companion animals hold nearly 60% market share, revenue from pet dogs is expected to contribute a major chunk.
Oral formulations will account for nearly 2/3 of the market share.
The U.S. dominates the North America vet compounding pharmacies market, owing to the presence of key players and increased R&D activities in this field.
Increased demand for flavoured medications that are easily accessible at compounding pharmacies will fuel market expansion, says an analyst of Persistence Market Research.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/33001
Market Competition
Rising need for animal compounding drugs has led leading players in the North America vet compounding pharmacies market to take initiatives such as providing home delivery services through local channel partners.
Wedgewood Pharmacy collaborated with Vetsource Company in order to use the Vetsource platform to ensure that Vetsources Home-Delivery catalogue would include thousands of routinely prescribed compounded pharmaceuticals created by Wedgewood pharmacy.
The Golden Gate Veterinary Compounding pharmacy launched a new initiative called the Text-to-Refill system, through which prescription refills were made easy for pet owners.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the North American vet compounding pharmacies market in its latest study, presenting a historical demand assessment of 2016 2020 and projections for 2021 2031.
The research study is based on products (CNS agents, anti-infective agents, hormones and substitutes, anti-inflammatory agents, and others), formulation (oral, injectables, and others), animal type (companion animals and livestock animals), across countries in North America.
Exclusive Reports of PMR-
Animal Parasiticide Market-
The global animal parasiticides market has registered a value of US$ 6,976.2 Mn in 2015 & is anticipated to reach a value of US$ 13,064.7 Mn by 2026 with a projected CAGR of 5.9%.
Orthopedic Veterinary Implants Market-
The global orthopedic veterinary implants market will exhibit a robust CAGR of over 8% during the forecast period (2019 2029).
Animal Drug Compounding Market-
The Global Animal Drug Compounding Market is expected to reach ~ US$ 1 Bn by the end of 2019 in terms of value and is forecasted to reach ~ US$ 2 Bn by the end of 2029.
Animal Parasiticide Market-
The global animal parasiticides market has registered a value of US$ 6,976.2 Mn in 2015 & is anticipated to reach a value of US$ 13,064.7 Mn by 2026 with a projected CAGR of 5.9%.
About us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact us:
Persistence Market Research
Address 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. +1-646-568-7751
USA-Canada Toll-free +1 800-961-0353
Sales sales@persistencemarketresearch.com
